- Home
- ERNA vs JFU Comparison
ERNA vs JFU Comparison
Compare ERNA & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- JFU
- Stock Information
- Founded
- ERNA 2018
- JFU 2006
- Country
- ERNA United States
- JFU China
- Employees
- ERNA N/A
- JFU N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- ERNA Health Care
- JFU Finance
- Exchange
- ERNA Nasdaq
- JFU Nasdaq
- Market Cap
- ERNA 14.2M
- JFU 15.8M
- IPO Year
- ERNA N/A
- JFU 2019
- Fundamental
- Price
- ERNA $0.18
- JFU $1.34
- Analyst Decision
- ERNA
- JFU
- Analyst Count
- ERNA 0
- JFU 0
- Target Price
- ERNA N/A
- JFU N/A
- AVG Volume (30 Days)
- ERNA 429.2K
- JFU 7.6K
- Earning Date
- ERNA 06-13-2025
- JFU 01-01-0001
- Dividend Yield
- ERNA N/A
- JFU N/A
- EPS Growth
- ERNA N/A
- JFU N/A
- EPS
- ERNA N/A
- JFU 0.09
- Revenue
- ERNA $535,000.00
- JFU $40,614,155.00
- Revenue This Year
- ERNA N/A
- JFU N/A
- Revenue Next Year
- ERNA N/A
- JFU N/A
- P/E Ratio
- ERNA N/A
- JFU $14.62
- Revenue Growth
- ERNA 365.22
- JFU N/A
- 52 Week Low
- ERNA $0.15
- JFU $1.01
- 52 Week High
- ERNA $2.63
- JFU $3.60
- Technical
- Relative Strength Index (RSI)
- ERNA 35.43
- JFU 49.59
- Support Level
- ERNA $0.16
- JFU $1.30
- Resistance Level
- ERNA $0.25
- JFU $1.48
- Average True Range (ATR)
- ERNA 0.03
- JFU 0.06
- MACD
- ERNA -0.01
- JFU -0.00
- Stochastic Oscillator
- ERNA 22.22
- JFU 21.05
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.